Amoxicillin-Clavulanic acid 600mg - 42.9 mg/ 5 mL oral suspension

DRUG2 trials

Sponsors

Ranbaxy Laboratories Limited, Eskisehir Osmangazi University

Conditions

ACUTE SINUSITISAcute Otitis MediaAntibiotic Associated DiarrheaHealthy

Phase 4

Effects of Saccharomyces Boulardii CNCM I-745 on Antibiotic-Associated Perturbation in Children Treated for Acute Respiratory Infections (RESTORE Study)

CompletedNCT07015736

Eskisehir Osmangazi UniversityAcute Otitis Media, ACUTE SINUSITIS, Antibiotic Associated Diarrhea

Start: 2025-08-01End: 2026-09-10Updated: 2026-09-11

Unknown Phase

Bioequivalence Study of Amoxicillin-Clavulanic Acid 600 mg - 42.9 mg/ 5 mL Oral Suspension Under Fasting Conditions

CompletedNCT00778414

Ranbaxy Laboratories LimitedHealthy

Start: 2006-06-30End: 2006-09-30Updated: 2008-10-23